Fred Alger Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $253K | Sell |
2,009
-265
| -12% | -$33.3K | ﹤0.01% | 411 |
|
|
2025
Q1 | $252K | Buy |
+2,274
| New | +$252K | ﹤0.01% | 398 |
|
|
2024
Q1 | – | Sell |
-7,339
| Closed | -$967K | – | 480 |
|
|
2023
Q4 | $967K | Sell |
7,339
-82,599
| -92% | -$10.9M | 0.01% | 369 |
|
|
2023
Q3 | $10.1M | Buy |
+89,938
| New | +$10.1M | 0.06% | 179 |
|
|
2023
Q2 | – | Sell |
-176
| Closed | -$17.8K | – | 554 |
|
|
2023
Q1 | $17.8K | Sell |
176
-206,521
| -100% | -$20.9M | ﹤0.01% | 501 |
|
|
2022
Q4 | $24.7M | Buy |
206,697
+206,473
| +92,175% | +$24.7M | 0.13% | 152 |
|
|
2022
Q3 | $24K | Hold |
224
| – | – | ﹤0.01% | 488 |
|
|
2022
Q2 | $22K | Buy |
+224
| New | +$22K | ﹤0.01% | 477 |
|
|
2020
Q2 | – | Sell |
-7,775
| Closed | -$673K | – | 567 |
|
|
2020
Q1 | $673K | Sell |
7,775
-30,550
| -80% | -$2.64M | ﹤0.01% | 345 |
|
|
2019
Q4 | $4.12M | Buy |
38,325
+10,023
| +35% | +$1.08M | 0.02% | 245 |
|
|
2019
Q3 | $2.55M | Buy |
28,302
+4,208
| +17% | +$379K | 0.01% | 268 |
|
|
2019
Q2 | $2.03M | Sell |
24,094
-17,421
| -42% | -$1.47M | 0.01% | 294 |
|
|
2019
Q1 | $3.66M | Sell |
41,515
-4,323
| -9% | -$381K | 0.01% | 248 |
|
|
2018
Q4 | $3.27M | Sell |
45,838
-14,446
| -24% | -$1.03M | 0.02% | 253 |
|
|
2018
Q3 | $7.41M | Sell |
60,284
-1,253
| -2% | -$154K | 0.03% | 190 |
|
|
2018
Q2 | $6.05M | Buy |
61,537
+15,315
| +33% | +$1.5M | 0.03% | 201 |
|
|
2018
Q1 | $3.83M | Buy |
46,222
+8,492
| +23% | +$704K | 0.02% | 248 |
|
|
2017
Q4 | $2.93M | Buy |
37,730
+31,905
| +548% | +$2.48M | 0.01% | 261 |
|
|
2017
Q3 | $357K | Buy |
5,825
+5,431
| +1,378% | +$333K | ﹤0.01% | 366 |
|
|
2017
Q2 | $18K | Sell |
394
-17,000
| -98% | -$777K | ﹤0.01% | 460 |
|
|
2017
Q1 | $753K | Sell |
17,394
-32,489
| -65% | -$1.41M | ﹤0.01% | 340 |
|
|
2016
Q4 | $1.93M | Buy |
49,883
+5,749
| +13% | +$222K | 0.01% | 263 |
|
|
2016
Q3 | $2.24M | Buy |
44,134
+6,014
| +16% | +$305K | 0.01% | 253 |
|
|
2016
Q2 | $1.73M | Sell |
38,120
-51,598
| -58% | -$2.35M | 0.01% | 284 |
|
|
2016
Q1 | $3.55M | Sell |
89,718
-71,698
| -44% | -$2.84M | 0.02% | 287 |
|
|
2015
Q4 | $9.13M | Sell |
161,416
-14,352
| -8% | -$812K | 0.04% | 190 |
|
|
2015
Q3 | $6.99M | Sell |
175,768
-110,541
| -39% | -$4.4M | 0.04% | 237 |
|
|
2015
Q2 | $13.7M | Sell |
286,309
-103,461
| -27% | -$4.94M | 0.06% | 193 |
|
|
2015
Q1 | $15.5M | Sell |
389,770
-236,041
| -38% | -$9.37M | 0.07% | 210 |
|
|
2014
Q4 | $14M | Buy |
625,811
+29,981
| +5% | +$670K | 0.07% | 216 |
|
|
2014
Q3 | $9.34M | Buy |
+595,830
| New | +$9.34M | 0.05% | 266 |
|
|
2013
Q4 | – | Sell |
-1,521
| Closed | -$17K | – | 590 |
|
|
2013
Q3 | $17K | Buy |
+1,521
| New | +$17K | ﹤0.01% | 503 |
|